[Identification of a cardiac allograft rejection marker using microarray gene expression analysis in lymphocytes from heart transplant patients].
نویسندگان
چکیده
The diagnosis of graft rejection is one of the fundamental aspects of caring for patients with heart transplantation. Endomyocardial biopsy (EMB) has important limitations, as it is an invasive procedure, with variable interpretation and limited sensitivity.1-3 Thus, it would be of interest to have a noninvasive diagnostic method that facilitates follow-up of patients with heart transplantation. The gene expression patterns of peripheral blood lymphocytes may represent a highly sensitive, highly specific tool that would identify patients who present rejection and avoid the inconvenience of EMB. We present the preliminary results of a study performed to determine a set of candidate genes for use in a noninvasive molecular expression test with peripheral blood to detect cardiac graft rejection. The experiments to analyze gene expression were conducted with 6 peripheral blood samples taken from heart transplant recipients on the day of EMB. Rejection was diagnosed according to the International Society of Heart and Lung Transplantation (ISHLT) classification.4 Three of the samples corresponded to patients with rejection (ISHLT Grade ≥2 ISHLT rejection) and three to patients without rejection (ISHLT Grade 0 rejection). The blood samples were collected in tubes containing a solution for RNA stabilization (PAXgene Blood RNA Tubes, Qiagen) and stored at –80oC until the time of analysis. Genetic tests were performed with Affymetrix microarrays (GeneChip Human Genome U133 Bonus 2.0 Array). Differences in the expression of 262 genes were found when using the GeneSpring comparison algorithm. Two-dimensional hierarchical cluster allows verification of the presence of differential expression patterns consisting of samples with rejection compared to the control samples. Of these 262 genes, Table lists the candidate genes. Five metabolic pathways with at least 2 genes of modified expression level were found. These metabolic pathways were: LETTERS TO THE EDITOR
منابع مشابه
Correlation of Corneal Allograft Rejection with Tumor Necrosis Factors-Alpha Gene Polymorphism
Background: Correlations between bone marrow, heart, kidney, liver, skin and lung transplant rejection or survival with human cytokine gene polymorphisms have been described. There are also reports about the role of cytokines and Tumor Necrosis Factors-Alpha (TNF-α) on corneal transplant in animal models. Further studies are needed to clarify the role of cytokines in corneal allograft rejection...
متن کاملEffect of Fas -670 A/G Gene Polymorphism on Corneal Allograft Endothelial Rejection
Background: Human cornea expresses functional Fas-ligand capable of killing Fas+ activated lymphocytes. Fas expression is partly regulated by -670 A/G polymorphism in the promoter region of Fas gene. Objective: The aim of the present study is to determine the association between Fas-670A/G polymorphism and survival of corneal transplantation. Methods: In 276 graft recipients who mainly underwen...
متن کاملEvaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
BACKGROUND Cardiac allograft rejection remains a significant clinical problem in the early phase after heart transplantation and requires frequent surveillance with endomyocardial biopsy. However, this is an invasive procedure, which is unpleasant for the patient and carries a certain risk. Therefore, a sensitive non-invasive biomarker of acute rejection would be desirable. METHODS Endomyocar...
متن کاملMicroRNAs as non-invasive biomarkers of heart transplant rejection.
AIM Rejection is one of the major causes of late cardiac allograft failure and at present can only be diagnosed by invasive endomyocardial biopsies. We sought to determine whether microRNA profiling could serve as a non-invasive biomarker of cardiac allograft rejection. METHODS We included 113 heart transplant recipients from four referral French institutions (test cohort, n = 60, validation ...
متن کاملRole of Soluble ST2 as a Marker for Rejection after Heart Transplant
BACKGROUND AND OBJECTIVES Endomyocardial biopsy is obligatory during the first year after heart transplant (HTx) for the surveillance of acute rejection. Previous attempts using cardiac biomarkers for the detection of rejection failed to show enough evidence to substitute endomyocardial biopsy. Therefore, this study sought the possibility of using soluble ST2 (sST2), a novel cardiovascular mark...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Revista espanola de cardiologia
دوره 60 2 شماره
صفحات -
تاریخ انتشار 2007